Rhythm Pharmaceuticals, Inc.
RYTM
Revenue
77.43M
▲53.79M▲227.56%
12 Months ChangeAssets
381.85M
▲123.20M▲47.63%
3 Months ChangeLiabilities
202.35M
▲5.28M▲2.68%
3 Months ChangeFree Cash Flow
-36.48M
▲17.28M▲32.14%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-09-19
Form 8-K
ID: 0001104659-24-101393
2024-08-06
Form 10-Q
ID: 0001558370-24-011101
2024-08-06
Form 8-K
ID: 0001104659-24-086081
2024-07-10
Form 8-K
ID: 0001104659-24-078941
2024-06-17
Form 8-K
ID: 0001104659-24-072376
2024-05-07
Form 10-Q
ID: 0001558370-24-007076
2024-05-07
Form 8-K
ID: 0001104659-24-057691
2024-04-16
Form 8-K
ID: 0001104659-24-047492
2024-04-01
Form 8-K
ID: 0001104659-24-041970
2024-02-29
Form 8-K
ID: 0001104659-24-029417